ArticleBioscience reports2020

Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway.

Fangzhen Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.